You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Luminal B

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Luminal B/HER2-negative Breast Cancer Trial in Hangzhou (Dalpiciclib combined with aromatase inhibitors,

Recruiting
  • Luminal B/HER2-negative Breast Cancer
  • Dalpiciclib combined with aromatase inhibitors
  • anthracycline-cyclophosphamide followed by taxane
  • Hangzhou, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Nov 30, 2022

Genomic Alteration in Luminal A or Luminal B Subtypes

Active, not recruiting
  • Breast Cancer
    • Athens, Greece
      George Fountzilas
    Mar 15, 2022

    Breast Cancer, Triple Negative Breast Cancer, Luminal B Trial in Belgium (Paclitaxel, Epirubicin, Cyclophosphamide)

    Active, not recruiting
    • Breast Cancer
    • +2 more
    • Charleroi, Hainaut, Belgium
    • +3 more
    Aug 2, 2022

    Blood Cytokine Values in Breast Cancers.

    Completed
    • Breast Cancer
    • Flow-Cytometric analysis
    • Istanbul, Turkey
      Istanbul Training and Research Hospital
    Aug 8, 2022

    Breast Cancer, Radiotherapy Trial in Bologna (SBRT anticipated boost)

    Recruiting
    • Breast Cancer
    • Radiotherapy
    • SBRT anticipated boost
    • Bologna, Italy
      IRCCS Azienda Ospedaliero-Universitaria di Bologna
    Jan 9, 2023

    Breast Cancer Female Trial in Clermont-Ferrand (blood samples collection)

    Recruiting
    • Breast Cancer Female
    • blood samples collection
    • Clermont-Ferrand, Puy-de-Dôme, France
      Centre Jean PERRIN
    Mar 9, 2022

    Physical Exercise on Tumor Proliferation of Luminal B Breast

    Active, not recruiting
    • Breast Cancer
    • Luminal B
    • Exercise
    • Stretching
    • Madrid, Spain
      Hospital General Universitario Gregorio Marañón
    Feb 2, 2022

    Breast Cancer Female, Lobular Breast Carcinoma, PET/MRI Trial (drug, procedure, genetic)

    Not yet recruiting
    • Breast Cancer Female
    • +4 more
    • (no location specified)
    Aug 8, 2023

    Metastatic Uveal Melanoma, Triple Negative Breast Cancer, Luminal B Breast Cancer Trial in Paris (Questionnaires,

    Recruiting
    • Metastatic Uveal Melanoma
    • +3 more
    • Questionnaires
    • +3 more
    • Paris, France
      Institut Curie
    Apr 6, 2022

    Early-Stage Breast Carcinoma, Estrogen Receptor Positive Tumor Trial in Stockholm (Paclitaxel, Tamoxifen + Palbociclib,

    Active, not recruiting
    • Early-Stage Breast Carcinoma
    • Estrogen Receptor Positive Tumor
    • Stockholm, Sweden
    • +2 more
    Jul 30, 2021

    Breast Cancer Trial in Milan (Caelyx®)

    Active, not recruiting
    • Breast Cancer
    • Milan, Italy
      European Institute of Oncology
    Feb 11, 2021

    Tumor, Breast, Congenital, Familial and Genetic Disorders Trial in Netherlands (Alpelisib 150 MG Oral Tablet [Piqray],

    Recruiting
    • Neoplasm, Breast
    • Congenital, Familial and Genetic Disorders
    • Almelo, Netherlands
    • +15 more
    Jan 11, 2023

    Breast Cancer, Sentinel Lymph Node Biopsy, Neoadjuvant Chemo Trial in Rijeka

    Enrolling by invitation
    • Breast Cancer
    • +2 more
      • Rijeka, Croatia
        Ana Car Peterko
      Aug 2, 2021

      Breast Cancer Trial in Italy (Epirubicin, Cyclophosphamide, Triptorelin)

      Completed
      • Breast Cancer
      • Cona, FE, Italy
      • +4 more
      Dec 2, 2020

      Breast Cancer Trial in Spain (Ribociclib, Letrozole 2.5mg, Doxorubicin)

      Completed
      • Breast Cancer
      • Barcelona, Spain
      • +20 more
      Mar 16, 2021

      Radiation Therapy, Breast Cancer, Sequential Partial Breast Irradiation, Intermediate and High-risk Luminal and Triple Negative

      Recruiting
      • Radiation Therapy, Breast Cancer, Sequential Partial Breast Irradiation
      • Intermediate and High-risk Luminal and Triple Negative Breast Cancer
      • Créteil, France
      • +5 more
      May 10, 2021

      Local Recurrence Following Breast Conserving Surgery and

      Active, not recruiting
      • Breast Cancer
        • Calgary, Alberta, Canada
        • +26 more
        Sep 19, 2022

        Breast Cancer Trial in Guangzhou (Endocrine therapy combined with trastuzumab, Chemotherapy combined with trastuzumab)

        Completed
        • Breast Cancer
        • Endocrine therapy combined with trastuzumab
        • Chemotherapy combined with trastuzumab
        • Guangzhou, Guangdong, China
          Sun Yat-sen University Cancer Center
        Jul 13, 2020

        Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 Trial

        Recruiting
        • Anatomic Stage IA Breast Cancer AJCC v8
        • +27 more
        • Aspiration of Breast
        • Biospecimen Collection
        • Columbus, Ohio
          Ohio State University Comprehensive Cancer Center
        Oct 29, 2021

        Breast Cancer Trial in Shanghai (Capecitabine, Vinorelbine)

        Unknown status
        • Breast Cancer
        • Shanghai, Shanghai, China
          Cancer Hospital/ Institute, Fudan University
        Mar 11, 2020

        After Neoadjuvant Using Excisional Biopsy By Radiofrequency In

        Terminated
        • Triple Negative, HER2+, Luminal B Breast Tumors (Stages II-III)in Female Patients
          • Madrid, Spain
            Hospital General Universitario Gregorio Marañón
          Aug 7, 2020

          Breast Cancer Trial in Istanbul (Soluble immune checkpoints)

          Recruiting
          • Breast Cancer
          • Soluble immune checkpoints
          • Istanbul, Turkey
          • +1 more
          Jul 14, 2022

          Early Luminal Breast Cancer and Pancreatic Cancer Patients

          Recruiting
          • Breast Cancer
          • Pancreas Cancer
          • Moscow, Not Required, Russian Federation
            Moscow Clinical Scientific Center named after AS Loginov
          Oct 12, 2022

          Breast Cancer, Oligometastasis, Metastatic Breast Cancer Trial in Tokyo (Systemic therapy for 12 weeks after primary

          Recruiting
          • Breast Cancer
          • +2 more
          • Systemic therapy for 12 weeks after primary registration
          • +3 more
          • Tokyo, Japan
            Tokyo Medical and Dental Univetsity
          Nov 15, 2023

          MACSSI (MAstectomie Cellules Souches Surveillance Immunitaire)

          Recruiting
          • Breast Cancer
          • Characterization of breast stem & immune system cells infiltrated in the mammary gland
          • Lyon, France
            Centre Léon Bérard
          Aug 26, 2022